Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:251-254, doi:10.1016/j.jacc.2008.04.019
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gori, T.
Right arrow Articles by Parker, J. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gori, T.
Right arrow Articles by Parker, J. D.
Related Collections
Right arrowRelated Article

VIEWPOINT

Nitrate-Induced Toxicity and Preconditioning

A Rationale for Reconsidering the Use of These Drugs

Tommaso Gori, MD, PhD*,{dagger},* and John D. Parker, MD, FACC{ddagger}

* Department of Internal, Cardiovascular, and Geriatric Medicine, University of Siena, Siena, Italy
{dagger} Medizinische Klinik, University of Mainz, Mainz, Germany
{ddagger} Division of Cardiology, Department of Medicine, Mount Sinai and University Health Network Hospitals, University of Toronto, Toronto, Ontario, Canada.

Manuscript received January 4, 2008; revised manuscript received March 26, 2008, accepted April 3, 2008.

* Reprint requests and correspondence: Dr. Tommaso Gori, Department of Internal, Cardiovascular, and Geriatric Medicine, University of Siena, Via Ciacci 42, Siena, Tuscany 53100, Italy. (Email: tommaso.gori{at}utoronto.ca).

Although organic nitrates have been clinically used for more than a century, findings in the last decade have radically challenged our traditional view concerning the mechanism(s) of their clinical effects and implications. While their hemodynamic properties are well known, the knowledge that nitrates possess previously unexpected nonhemodynamic effects is a unique opportunity of which clinicians should be aware but, at the same time, it also provides a rationale to worry about previously unanticipated clinical consequences of long-term treatment with these drugs.

Key Words: nitroglycerin • ischemia • angina • preconditioning


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A23-A24. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
T. Munzel and T. Gori
Nebivolol The Somewhat-Different beta-Adrenergic Receptor Blocker.
J. Am. Coll. Cardiol., October 13, 2009; 54(16): 1491 - 1499.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement